腮腺浅叶切除术后,暂时性面瘫发生率约1/3-2/3。[25]Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622.http://www.ncbi.nlm.nih.gov/pubmed/11092780?tool=bestpractice.com[26]Moody AB, Avery CM, Taylor J, et al. A comparison of 150 consecutive parotidectomies for tumours and inflammatory disease. Int J Oral Maxillofac Surg. 1999;28:211-215.http://www.ncbi.nlm.nih.gov/pubmed/10355945?tool=bestpractice.com[27]Amin MA, Bailey BM, Patel SR. Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg. 2001;39:348-352.http://www.ncbi.nlm.nih.gov/pubmed/11601814?tool=bestpractice.com[28]Patel RS, Low TH, Gao K, et al. Clinical outcome after surgery for 75 patients with parotid sialadenitis. Laryngoscope. 2007;117:644-647.http://www.ncbi.nlm.nih.gov/pubmed/17415134?tool=bestpractice.com对美观的影响相对轻微,但症状复发率可能高达 11-13%,[25]Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622.http://www.ncbi.nlm.nih.gov/pubmed/11092780?tool=bestpractice.com[27]Amin MA, Bailey BM, Patel SR. Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg. 2001;39:348-352.http://www.ncbi.nlm.nih.gov/pubmed/11601814?tool=bestpractice.com尽管并非所有患者都需进一步治疗。全腮腺切除术后美观缺损更为明显并且对面神经的风险稍高,尽管还尚未被证实。[28]Patel RS, Low TH, Gao K, et al. Clinical outcome after surgery for 75 patients with parotid sialadenitis. Laryngoscope. 2007;117:644-647.http://www.ncbi.nlm.nih.gov/pubmed/17415134?tool=bestpractice.com症状复发的风险可能较低,<4%,[28]Patel RS, Low TH, Gao K, et al. Clinical outcome after surgery for 75 patients with parotid sialadenitis. Laryngoscope. 2007;117:644-647.http://www.ncbi.nlm.nih.gov/pubmed/17415134?tool=bestpractice.com尽管在这系列中腮腺浅叶切除术的复发率更低。疾病的范围以及患者的决定同样影响外科术式的选择。面部无力的模式有可能累及一个或多个神经分支并且通常是全面部,[25]Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622.http://www.ncbi.nlm.nih.gov/pubmed/11092780?tool=bestpractice.com[26]Moody AB, Avery CM, Taylor J, et al. A comparison of 150 consecutive parotidectomies for tumours and inflammatory disease. Int J Oral Maxillofac Surg. 1999;28:211-215.http://www.ncbi.nlm.nih.gov/pubmed/10355945?tool=bestpractice.com 因为腺体内纤维化广泛。一般恢复期需要3-6个月并且是通常完全恢复。永久性面瘫发生率<1%。[25]Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622.http://www.ncbi.nlm.nih.gov/pubmed/11092780?tool=bestpractice.com[26]Moody AB, Avery CM, Taylor J, et al. A comparison of 150 consecutive parotidectomies for tumours and inflammatory disease. Int J Oral Maxillofac Surg. 1999;28:211-215.http://www.ncbi.nlm.nih.gov/pubmed/10355945?tool=bestpractice.com[27]Amin MA, Bailey BM, Patel SR. Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg. 2001;39:348-352.http://www.ncbi.nlm.nih.gov/pubmed/11601814?tool=bestpractice.com[28]Patel RS, Low TH, Gao K, et al. Clinical outcome after surgery for 75 patients with parotid sialadenitis. Laryngoscope. 2007;117:644-647.http://www.ncbi.nlm.nih.gov/pubmed/17415134?tool=bestpractice.com淤血、血肿、或明显感染的发生率应<5%。[25]Moody AB, Avery CM, Walsh S, et al. Surgical management of chronic parotid disease. Br J Oral Maxillofac Surg. 2000;38:620-622.http://www.ncbi.nlm.nih.gov/pubmed/11092780?tool=bestpractice.com[26]Moody AB, Avery CM, Taylor J, et al. A comparison of 150 consecutive parotidectomies for tumours and inflammatory disease. Int J Oral Maxillofac Surg. 1999;28:211-215.http://www.ncbi.nlm.nih.gov/pubmed/10355945?tool=bestpractice.com
|